Frederick R. Singer, MD, John Wayne Cancer Inst Disclosure:Frederick R. Singer, MD, has received speaker honoraria from Novartis.
Frederick R. Singer is Director of the Endocrine/Bone Disease Program at the John Wayne Cancer Institute at Saint John’s Health Center, Santa Monica, California and is Clinical Professor of Medicine at UCLA School of Medicine. Dr. Singer is past Chairman of the Board of Directors of the Paget Foundation and past president of the American Society for Bone and Mineral Research. He has served on many national public health committees, including as chairman of the USPHS FDA Endocrinologic Metabolic Drug Advisory Committee, on NIAMSD ad hoc review groups on osteoporosis, and as co-chairman of the NIAMSD National Research Plan Task Force on Bone Biology and Bone Diseases. He also was Chairman of the National Cancer Institute Special Study Section on Molecular Interactions Between Tumor Cells and Bone in 2003. Dr. Singer has served on the editorial boards of Calcified Tissue International, Journal of Bone and Mineral Research, Journal of Clinical Endocrinology and Metabolism, and Osteoporosis International, Dr. Singer received his MD degree from the University of California School of Medicine, San Francisco in 1963. He completed his postgraduate training in internal medicine at the University of California Affiliated Hospitals, Los Angeles, followed by research fellowships in endocrinology at the Royal Postgraduate Medical School, London and the Massachusetts General Hospital, Boston, Massachusetts. His research interests are skeletal complications of malignancy, Paget’s disease of bone, primary hyperparathyroidism, osteoporosis and the effect of vitamin D on breast cancer.